comparemela.com

Apollomics Chart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Apollomics Announces Two New Cohorts in Global Phase 2 SPARTA Study of Vebreltinib in Non-Small Cell Lung Cancer and Other Solid Tumors with MET Dysregulation

31.10.2023 - FOSTER CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) - Apollomics Inc. (Nasdaq: APLM), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today . Seite 1

Bindiya patelWashington university school of medicineChief medical officerWashington university schoolSiddhartha devarakondaWorld conferenceLung cancerApollomics chartPollomics kursPollomics aktie

Apollomics Announces Presentations of Vebreltinib Data at ESMO 2023

17.10.2023 - FOSTER CITY, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) - Apollomics Inc. (Nasdaq: APLM) (the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and . Seite 1

Jin ji yangGuo liang yuGiulia cerretti veneto institute of oncologySouthern medical universityVeneto institute of oncologyGuangdong academy of medical sciencesGuangdong lung cancer instituteChief executive officerPreliminary resultsGuangdong provincial peopleGuangdong academyMedical sciencesVeneto instituteGiulia cerrettiMini oralApollomics chart

vimarsana © 2020. All Rights Reserved.